GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,000 | 0.0% | 250 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $11,000 | +10.0% | 250 | -9.1% | 0.00% | 0.0% |
| Q4 2020 | $10,000 | +25.0% | 275 | +44.0% | 0.00% | +50.0% |
| Q2 2019 | $8,000 | 0.0% | 191 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $8,000 | +14.3% | 191 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $7,000 | -12.5% | 191 | +1.6% | 0.00% | -33.3% |
| Q3 2018 | $8,000 | -63.6% | 188 | -66.0% | 0.00% | -57.1% |
| Q2 2018 | $22,000 | 0.0% | 553 | -3.7% | 0.01% | +40.0% |
| Q1 2018 | $22,000 | -81.0% | 574 | -80.9% | 0.01% | -83.9% |
| Q4 2016 | $116,000 | -10.1% | 3,000 | 0.0% | 0.03% | -18.4% |
| Q3 2016 | $129,000 | -0.8% | 3,000 | 0.0% | 0.04% | -13.6% |
| Q2 2016 | $130,000 | +6400.0% | 3,000 | +6283.0% | 0.04% | +4300.0% |
| Q4 2015 | $2,000 | – | 47 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |